Deputy Director for Clinical Care Named

John Buatti, MD, professor and head of the Department of Radiation Oncology at the University of Iowa Roy J. and Lucille A. Carver College of Medicine and University of Iowa Hospitals and Clinics, has been appointed deputy director for clinical care for Holden Comprehensive Cancer Center at the UI.

In this new role, Buatti oversees and coordinates all clinical activities in Holden Comprehensive Cancer Center. He also will work with medical center and cancer center leadership to develop a plan to provide excellent care to cancer patients while growing volume in the cancer service line.

As deputy director for clinical care, Buatti reports to Cancer Center Director George Weiner, MD, and the chief executive officer of UI Hospitals and Clinics. Buatti will continue to serve as professor and head of radiation oncology.

Buatti came to the UI from the University of Florida in 1999 to serve as division director of radiation oncology, and in 2001 became chair of the newly created Department of Radiation Oncology.

"Dr. Buatti has done a tremendous job creating a patient-centered environment and delivering state-of-the-art cancer care in our Center of Excellence in Image-Guided Radiation Therapy. He is a great addition to our Holden Comprehensive Cancer Center leadership team," Weiner said.

John Buatti, MD

For more information:

John Buatti, MD

George Weiner, MD

University of Iowa Roy J. and Lucille A. Carver College of Medicine

Holden Comprehensive Cancer Center

Weiner Named to Cancer Clinical Trials Leadership Group

George Weiner, MD, director of the Holden Comprehensive Cancer at the University of Iowa, will join a group of cancer center leaders nationwide who are looking at ways to expedite the process of cancer clinical trials in the United States.

Weiner will serve on the Operational Efficiency Working Group of the National Cancer Institute's (NCI) Clinical Trials Working Group, which aims to identify and reduce institutional or other factors that prolong the time from a clinical trial's conceptual approval to actual patient recruitment.

Weiner was selected for his expertise in conducting clinical trials and for his role as director of an NCI-designated cancer center. Weiner also is currently serving his second year as chairman of the NCI committee that reviews the nation's top cancer research centers.

George Weiner, MD

For more information:

George Weiner, MD

Holden Comprehensive Cancer at the University of Iowa

National Cancer Institute's (NCI)